home All News open_in_new Full Article

Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025

CAMBRIDGE, Mass. & MONTREAL — Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the acceptance of four abstracts for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in […]


today 5 h. ago attach_file Other

attach_file Other
attach_file Sport
attach_file Science
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Culture
attach_file Other
attach_file Other


ID: 3233760801
Add Watch Country

arrow_drop_down